These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10445610)

  • 1. Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study.
    du Bois RM; Greenhalgh PM; Southcott AM; Johnson NM; Harris TA
    Eur Respir J; 1999 Jun; 13(6):1345-50. PubMed ID: 10445610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
    Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J
    Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of fluticasone in acute symptomatic pulmonary sarcoidosis.
    Baughman RP; Iannuzzi MC; Lower EE; Moller DR; Balkissoon RC; Winget DB; Judson MA
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):198-204. PubMed ID: 12405489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC; Marone G; Di Maria GU; Visser S; Utama I; Payne SL
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo controlled trial of fluticasone propionate in asthmatic children.
    MacKenzie CA; Weinberg EG; Tabachnik E; Taylor M; Havnen J; Crescenzi K
    Eur J Pediatr; 1993 Oct; 152(10):856-60. PubMed ID: 8223792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
    Burge PS; Calverley PM; Jones PW; Spencer S; Anderson JA; Maslen TK
    BMJ; 2000 May; 320(7245):1297-303. PubMed ID: 10807619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled short-term trial of fluticasone propionate in ventilator-dependent patients with COPD.
    Nava S; Compagnoni ML
    Chest; 2000 Oct; 118(4):990-9. PubMed ID: 11035668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
    Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R; Rachelefsky G; Harris AG; Chen R
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
    Boe J; Bakke P; Rødølen T; Skovlund E; Gulsvik A
    Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
    Lawrence M; Wolfe J; Webb DR; Chervinsky P; Kellerman D; Schaumberg JP; Shah T
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
    Dahl R; Lundback B; Malo JL; Mazza JA; Nieminen MM; Saarelainen P; Barnacle H
    Chest; 1993 Nov; 104(5):1352-8. PubMed ID: 8222787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in females.
    Convery RP; Leitch DN; Bromly C; Ward RJ; Bartlett G; Hendrick DJ
    Eur Respir J; 2000 Jan; 15(1):19-24. PubMed ID: 10678615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.